Freenome, Siemens Join Forces to Develop Blood Test for Breast Cancer
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The humble mammogram may soon be getting a complementary new partner to boost breast cancer screening, Fierce Biotech reports.
The acquisition aims to create a new patient acquisition channel by connecting aesthetic practices with corporate skin health and wellness programs.